Should clinicians treat osteopenic women 65 years of age or older who are at a high risk for fracture with medications to prevent fractures?
The American College of Physicians issued an updated clinical practice guideline recommending shared decision-making for the pharmacological treatment of osteopenic women aged 65 and older at high risk for fracture.
ACP recommends that clinicians should make the decision whether to treat osteopenic women 65 years of age or older who are at a high risk for fracture based on a discussion of patient preferences, fracture risk profile, and benefits, harms, and costs of medications. (Grade: weak recommendation; low-quality evidence).
Qaseem et al. (2017) studied this question.